Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance
- PMID: 2444874
- PMCID: PMC367939
- DOI: 10.1128/mcb.7.9.3076-3083.1987
Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance
Abstract
A clonal cell line (56-42) that was stably and exclusively resistant to the toxic effects of the antileukemic agent 5-aza-2'-deoxycytidine (5-aza-CdR) was derived from C3H 10T1/2 C18 cells after multiple treatments with 5-aza-CdR. The 50% lethal dose of 5-aza-CdR for these cells was 1.3 microM, which was 15-fold greater than that for the parental cells. Cell line 56-42 was slightly cross-resistant to the ribo-analog 5-azacytidine, but was sensitive to the nucleoside analog 1-beta-D-arabinofuranosylcytosine and to colcemid. Both parental and resistant cell lines incorporated equimolar amounts of 5-aza-CdR into DNA. Resistance was therefore not due to decreased activation, increased detoxification, or reduced incorporation of the drug. The overall level of cytosine methylation in the resistant clone was 80% lower than the level in the sensitive cells. Therefore, the potential number of hemimethylated sites created by the incorporation of equivalent amounts of 5-aza-CdR into the DNA of the two cell types was much greater in the sensitive cells. Furthermore, 5-azacytosine-substituted DNA from the sensitive cells bound 100% more nuclear protein in the form of highly stable complexes. The incorporation of 5-aza-CdR opposite methylated cytosine residues in DNA of the sensitive cells thus resulted in increased nuclear protein binding at hemimethylated sites. This relative increase in tight-binding protein complexes was shown to occur in living cells and may well disrupt replication and transcription and instigate cell death. The differential binding of proteins to hypomethylated, azacytosine-containing DNA may thus mediate a novel mechanism of drug resistance.
Similar articles
-
DNA methylation in 5-aza-2'-deoxycytidine-resistant variants of C3H 10T1/2 C18 cells.Mol Cell Biol. 1984 Oct;4(10):2098-102. doi: 10.1128/mcb.4.10.2098-2102.1984. Mol Cell Biol. 1984. PMID: 6209556 Free PMC article.
-
5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.Mol Cell Biol. 2005 Jun;25(11):4727-41. doi: 10.1128/MCB.25.11.4727-4741.2005. Mol Cell Biol. 2005. Retraction in: Mol Cell Biol. 2022 May 19;42(5):e0054621. doi: 10.1128/mcb.00546-21 PMID: 15899874 Free PMC article. Retracted.
-
Cellular differentiation, cytidine analogs and DNA methylation.Cell. 1980 May;20(1):85-93. doi: 10.1016/0092-8674(80)90237-8. Cell. 1980. PMID: 6156004
-
Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.Leukemia. 1997 Feb;11(2):175-80. doi: 10.1038/sj.leu.2400550. Leukemia. 1997. PMID: 9009076 Review.
-
Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.Leukemia. 1997 Mar;11 Suppl 1:S1-6. Leukemia. 1997. PMID: 9130684 Review.
Cited by
-
Trichostatin A-Mediated Epigenetic Modulation Predominantly Triggers Transcriptomic Alterations in the Ex Vivo Expanded Equine Chondrocytes.Int J Mol Sci. 2022 Oct 29;23(21):13168. doi: 10.3390/ijms232113168. Int J Mol Sci. 2022. PMID: 36361948 Free PMC article.
-
High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene.Biochemistry. 2010 Feb 23;49(7):1507-21. doi: 10.1021/bi9016846. Biochemistry. 2010. PMID: 20041635 Free PMC article.
-
Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS).Int J Mol Sci. 2022 Sep 14;23(18):10699. doi: 10.3390/ijms231810699. Int J Mol Sci. 2022. PMID: 36142605 Free PMC article.
-
(Some) cellular mechanisms influencing the transcription of human endogenous retrovirus, HERV-Fc1.PLoS One. 2013;8(1):e53895. doi: 10.1371/journal.pone.0053895. Epub 2013 Jan 28. PLoS One. 2013. PMID: 23382858 Free PMC article.
-
Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.PLoS One. 2011;6(12):e29450. doi: 10.1371/journal.pone.0029450. Epub 2011 Dec 22. PLoS One. 2011. PMID: 22216282 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources